4//SEC Filing
PATEL RAJIV A 4
Accession 0001182489-17-000451
CIK 0001618561other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:09 PM ET
Size
8.1 KB
Accession
0001182489-17-000451
Insider Transaction Report
Form 4
PATEL RAJIV A
Director10% OwnerOther
Transactions
- Disposition to Issuer
Ordinary Shares
2017-07-31$6.72/sh−13,580$91,258→ 0 total - Disposition to Issuer
Restricted Share Units
2017-07-31$6.59/sh−1,000$6,595→ 0 total→ Ordinary Shares (1,000 underlying)
Footnotes (4)
- [F1]Each Restricted Share Unit ("RSU") is convertible into one ordinary share of the Issuer upon vesting, subject to payment by the holder to the Issuer of the nominal value per share ($0.125).
- [F2]The 1,000 RSUs held by Patel were scheduled to vest and become convertible in quarterly installments of 500 on September 30, 2017 and December 31, 2017. Such RSUs were canceled in the Acquisition, as described below.
- [F3]Disposed of pursuant to a transaction agreement among the Issuer, Zoetis Inc. ("Zoetis") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis ("Bidco"), pursuant to which Bidco acquired all of the issued and to-be-issued ordinary share capital of the Issuer (the "Acquisition").
- [F4]These RSUs, which were not yet vested, were cancelled in the Acquisition in exchange for a total cash payment equal to $6,595, representing the difference between the conversion payment of $0.125 per RSU and the $6.72 consideration per ordinary share payable in connection with the Acquisition, multiplied by the 1,000 ordinary shares issuable upon the vesting and conversion of such RSUs.
Documents
Issuer
Nexvet Biopharma plc
CIK 0001618561
Entity typeother
Related Parties
1- filerCIK 0001275110
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:09 PM ET
- Size
- 8.1 KB